MLRagent
Rules/indication on label/US-IND-008

Communication must not suggest use outside approved patient population

AI-verifiedblockerFDA guidance · non-bindingRaised as a question — a person decides

Rule

If the patient population represented or suggested in a product communication falls outside the approved patient population in the FDA-required labeling, the communication is not consistent with the FDA-required labeling.

Check

Identify the population depicted or described (age, disease stage, prior therapy, severity, etc.) and compare it to the approved population in labeling. A violation looks like imagery, testimonials, or claims involving patients outside the labeled population.

Escalate when

The population depicted is not explicitly stated but could be reasonably inferred as outside the approved population (e.g., imagery suggesting a different age group or severity).

Where this comes from

Q.2/A.2, Factor 1 (Patient Population) · page 8. The highlighted words are quoted exactly; a script confirms they appear in the source before the rule can be published.

…s, that indicates the product communication is not consistent with the FDA-required labeling: https://www.fda.gov/RegulatoryInformation/Guidances/default.htm </u>. Contains Nonbinding Recommendations Indication – Do the representations/suggestions about the product in the communication relate to a different indication than the one(s) reflected in the product’s FDA-required labeling? Patient Population – Is the patient population represented or suggested in the communication outside the approved patient population reflected in the FDA-required labeling? Limitations and Directions for Handling/Use – Do the representations/suggestions in the communication conflict with the use limitations or directions for handling, preparing, and/or using the product reflected in the FDA-required labeling? Dosing or Use Regimen/Administration – Do the representations/suggestions about the product conflict with the recommended dosage or use regimen, route of administrat…
Open the original at page 8 on fda.gov ↗Read our full copy →
Document
FDA guidance: Medical Product Communications that Are Consistent With the FDA-Required Labeling – Questions and Answers (final)
Version
as retrieved — the publisher does not version this document; the fingerprint below identifies the exact file
Retrieved
2026-09-21 from www.fda.gov
Fingerprint
1a18b7f242bfbbf897f198df…

FDA guidance describes the agency's current thinking. It is not binding law, and this rule is a recommendation, not an obligation.